Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System

Kathy Mac Laughlin, Maya E. Kessler, Ravikumar Komandur Elayavilli, Branden C. Hickey, Marianne R. Scheitel, Kavishwar B. Wagholikar, Hongfang D Liu, Walter K Kremers, Rajeev Chaudhry

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: A clinical decision support system (CDSS) for cervical cancer screening identifies patients due for routine cervical cancer screening. Yet, high-risk patients who require more frequent screening or earlier follow-up to address past abnormal results are not identified. We aimed to assess the effect of a complex CDSS, incorporating national guidelines for high-risk patient screening and abnormal result management, its implementation to identify patients overdue for testing, and the outcome of sending a targeted recommendation for follow-up. Materials and Methods: At three primary care clinics affiliated with an academic medical center, a reminder recommending an appointment for Papanicolaou (Pap) testing or Pap and human papillomavirus cotesting was sent to high-risk women aged 18 through 65 years (intervention group) identified by CDSS as overdue for testing. Historical control patients, who did not receive a reminder, were identified by CDSS 1 year before the date when reminders were sent to the intervention group. Test completion rates were compared between the intervention and control groups through a generalized estimating equation extension. Results: Across the three sites, the average completion rate of recommended follow-up testing was significantly higher in the intervention group at 23.7% (61/257) than the completion rate at 3.3% (17/516) in the control group (p < 0.001). Conclusions: A CDSS with enhanced capabilities to identify high-risk women due for cervical cancer testing beyond routine screening intervals, with subsequent patient notification, has the potential to decrease cervical precancer and cancer by improving adherence to guideline-compliant follow-up and needed treatment.

Original languageEnglish (US)
Pages (from-to)569-574
Number of pages6
JournalJournal of Women's Health
Volume27
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Clinical Decision Support Systems
Papanicolaou Test
Uterine Cervical Neoplasms
Early Detection of Cancer
Guideline Adherence
Control Groups
Primary Health Care
Appointments and Schedules
Guidelines

Keywords

  • Abnormal Pap management
  • Cervical cancer prevention
  • Clinical decision support
  • Human papillomavirus

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System. / Mac Laughlin, Kathy; Kessler, Maya E.; Komandur Elayavilli, Ravikumar; Hickey, Branden C.; Scheitel, Marianne R.; Wagholikar, Kavishwar B.; Liu, Hongfang D; Kremers, Walter K; Chaudhry, Rajeev.

In: Journal of Women's Health, Vol. 27, No. 5, 01.05.2018, p. 569-574.

Research output: Contribution to journalArticle

Mac Laughlin, Kathy ; Kessler, Maya E. ; Komandur Elayavilli, Ravikumar ; Hickey, Branden C. ; Scheitel, Marianne R. ; Wagholikar, Kavishwar B. ; Liu, Hongfang D ; Kremers, Walter K ; Chaudhry, Rajeev. / Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System. In: Journal of Women's Health. 2018 ; Vol. 27, No. 5. pp. 569-574.
@article{188d36ffa5c443cca529b5942073a5f8,
title = "Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System",
abstract = "Background: A clinical decision support system (CDSS) for cervical cancer screening identifies patients due for routine cervical cancer screening. Yet, high-risk patients who require more frequent screening or earlier follow-up to address past abnormal results are not identified. We aimed to assess the effect of a complex CDSS, incorporating national guidelines for high-risk patient screening and abnormal result management, its implementation to identify patients overdue for testing, and the outcome of sending a targeted recommendation for follow-up. Materials and Methods: At three primary care clinics affiliated with an academic medical center, a reminder recommending an appointment for Papanicolaou (Pap) testing or Pap and human papillomavirus cotesting was sent to high-risk women aged 18 through 65 years (intervention group) identified by CDSS as overdue for testing. Historical control patients, who did not receive a reminder, were identified by CDSS 1 year before the date when reminders were sent to the intervention group. Test completion rates were compared between the intervention and control groups through a generalized estimating equation extension. Results: Across the three sites, the average completion rate of recommended follow-up testing was significantly higher in the intervention group at 23.7{\%} (61/257) than the completion rate at 3.3{\%} (17/516) in the control group (p < 0.001). Conclusions: A CDSS with enhanced capabilities to identify high-risk women due for cervical cancer testing beyond routine screening intervals, with subsequent patient notification, has the potential to decrease cervical precancer and cancer by improving adherence to guideline-compliant follow-up and needed treatment.",
keywords = "Abnormal Pap management, Cervical cancer prevention, Clinical decision support, Human papillomavirus",
author = "{Mac Laughlin}, Kathy and Kessler, {Maya E.} and {Komandur Elayavilli}, Ravikumar and Hickey, {Branden C.} and Scheitel, {Marianne R.} and Wagholikar, {Kavishwar B.} and Liu, {Hongfang D} and Kremers, {Walter K} and Rajeev Chaudhry",
year = "2018",
month = "5",
day = "1",
doi = "10.1089/jwh.2017.6667",
language = "English (US)",
volume = "27",
pages = "569--574",
journal = "Journal of women's health (2002)",
issn = "1540-9996",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System

AU - Mac Laughlin, Kathy

AU - Kessler, Maya E.

AU - Komandur Elayavilli, Ravikumar

AU - Hickey, Branden C.

AU - Scheitel, Marianne R.

AU - Wagholikar, Kavishwar B.

AU - Liu, Hongfang D

AU - Kremers, Walter K

AU - Chaudhry, Rajeev

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Background: A clinical decision support system (CDSS) for cervical cancer screening identifies patients due for routine cervical cancer screening. Yet, high-risk patients who require more frequent screening or earlier follow-up to address past abnormal results are not identified. We aimed to assess the effect of a complex CDSS, incorporating national guidelines for high-risk patient screening and abnormal result management, its implementation to identify patients overdue for testing, and the outcome of sending a targeted recommendation for follow-up. Materials and Methods: At three primary care clinics affiliated with an academic medical center, a reminder recommending an appointment for Papanicolaou (Pap) testing or Pap and human papillomavirus cotesting was sent to high-risk women aged 18 through 65 years (intervention group) identified by CDSS as overdue for testing. Historical control patients, who did not receive a reminder, were identified by CDSS 1 year before the date when reminders were sent to the intervention group. Test completion rates were compared between the intervention and control groups through a generalized estimating equation extension. Results: Across the three sites, the average completion rate of recommended follow-up testing was significantly higher in the intervention group at 23.7% (61/257) than the completion rate at 3.3% (17/516) in the control group (p < 0.001). Conclusions: A CDSS with enhanced capabilities to identify high-risk women due for cervical cancer testing beyond routine screening intervals, with subsequent patient notification, has the potential to decrease cervical precancer and cancer by improving adherence to guideline-compliant follow-up and needed treatment.

AB - Background: A clinical decision support system (CDSS) for cervical cancer screening identifies patients due for routine cervical cancer screening. Yet, high-risk patients who require more frequent screening or earlier follow-up to address past abnormal results are not identified. We aimed to assess the effect of a complex CDSS, incorporating national guidelines for high-risk patient screening and abnormal result management, its implementation to identify patients overdue for testing, and the outcome of sending a targeted recommendation for follow-up. Materials and Methods: At three primary care clinics affiliated with an academic medical center, a reminder recommending an appointment for Papanicolaou (Pap) testing or Pap and human papillomavirus cotesting was sent to high-risk women aged 18 through 65 years (intervention group) identified by CDSS as overdue for testing. Historical control patients, who did not receive a reminder, were identified by CDSS 1 year before the date when reminders were sent to the intervention group. Test completion rates were compared between the intervention and control groups through a generalized estimating equation extension. Results: Across the three sites, the average completion rate of recommended follow-up testing was significantly higher in the intervention group at 23.7% (61/257) than the completion rate at 3.3% (17/516) in the control group (p < 0.001). Conclusions: A CDSS with enhanced capabilities to identify high-risk women due for cervical cancer testing beyond routine screening intervals, with subsequent patient notification, has the potential to decrease cervical precancer and cancer by improving adherence to guideline-compliant follow-up and needed treatment.

KW - Abnormal Pap management

KW - Cervical cancer prevention

KW - Clinical decision support

KW - Human papillomavirus

UR - http://www.scopus.com/inward/record.url?scp=85047434262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047434262&partnerID=8YFLogxK

U2 - 10.1089/jwh.2017.6667

DO - 10.1089/jwh.2017.6667

M3 - Article

C2 - 29297754

AN - SCOPUS:85047434262

VL - 27

SP - 569

EP - 574

JO - Journal of women's health (2002)

JF - Journal of women's health (2002)

SN - 1540-9996

IS - 5

ER -